Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

Both Ozempic and Wegovy are forms of semaglutide, a GLP-1 agonist drug manufactured by Novo Nordisk. When reached for comment ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.People who r ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis ...

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...

There are two ways to be eligible for a Wegovy prescription: Have a BMI of 30 or higher Have a BMI of 27 or higher and a ...

Wegovy (semaglutide) is a prescription medication belonging to a group of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It comes as a liquid solution that you self-inject just ...